Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

EssilorLuxottica SA

ESLOYPNK
Healthcare
Medical - Instruments & Supplies
$116.69
$-4.29(-3.55%)
U.S. Market opens in 4h 32m

EssilorLuxottica SA Fundamental Analysis

EssilorLuxottica SA (ESLOY) shows weak financial fundamentals with a PE ratio of 41.22, profit margin of 8.13%, and ROE of 6.02%. The company generates $28.4B in annual revenue with moderate year-over-year growth of 4.38%.

Key Strengths

PEG Ratio-12.95

Areas of Concern

ROE6.02%
Cash Position3.28%
Current Ratio0.99
We analyze ESLOY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 43.3/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
43.3/100

We analyze ESLOY's fundamental strength across five key dimensions:

Efficiency Score

Weak

ESLOY struggles to generate sufficient returns from assets.

ROA > 10%
3.61%

Valuation Score

Moderate

ESLOY shows balanced valuation metrics.

PE < 25
41.22
PEG Ratio < 2
-12.95

Growth Score

Weak

ESLOY faces weak or negative growth trends.

Revenue Growth > 5%
4.38%
EPS Growth > 10%
1.76%

Financial Health Score

Moderate

ESLOY shows balanced financial health with some risks.

Debt/Equity < 1
0.44
Current Ratio > 1
0.99

Profitability Score

Weak

ESLOY struggles to sustain strong margins.

ROE > 15%
6.02%
Net Margin ≥ 15%
8.13%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ESLOY Expensive or Cheap?

P/E Ratio

ESLOY trades at 41.22 times earnings. This suggests a premium valuation.

41.22

PEG Ratio

When adjusting for growth, ESLOY's PEG of -12.95 indicates potential undervaluation.

-12.95

Price to Book

The market values EssilorLuxottica SA at 2.45 times its book value. This may indicate undervaluation.

2.45

EV/EBITDA

Enterprise value stands at 13.70 times EBITDA. This signals the market has high growth expectations.

13.70

How Well Does ESLOY Make Money?

Net Profit Margin

For every $100 in sales, EssilorLuxottica SA keeps $8.13 as profit after all expenses.

8.13%

Operating Margin

Core operations generate 11.84 in profit for every $100 in revenue, before interest and taxes.

11.84%

ROE

Management delivers $6.02 in profit for every $100 of shareholder equity.

6.02%

ROA

EssilorLuxottica SA generates $3.61 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.61%

Following the Money - Real Cash Generation

Operating Cash Flow

EssilorLuxottica SA produces operating cash flow of $5.40B, showing steady but balanced cash generation.

$5.40B

Free Cash Flow

EssilorLuxottica SA generates strong free cash flow of $3.84B, providing ample flexibility for dividends, buybacks, or growth.

$3.84B

FCF Per Share

Each share generates $4.14 in free cash annually.

$4.14

FCF Yield

ESLOY converts 4.06% of its market value into free cash.

4.06%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

41.22

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-12.95

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.35

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.99

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.06

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How ESLOY Stacks Against Its Sector Peers

MetricESLOY ValueSector AveragePerformance
P/E Ratio41.2228.25 Worse (Expensive)
ROE6.02%780.00% Weak
Net Margin8.13%-20122.00% (disorted) Weak
Debt/Equity0.440.30 Weak (High Leverage)
Current Ratio0.994.66 Weak Liquidity
ROA3.61%-14687.00% (disorted) Weak

ESLOY outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews EssilorLuxottica SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

45.77%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

109.46%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

41.28%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ